First Page | Meta Content | |
---|---|---|
Erratum to the FDA Briefing Document Dermatologic and Ophthalmic Drugs Advisory Committee Meeting March 9, 2015 NDA[removed], Deoxycholic acid for the improvement in the appearance of moderate to severe convexity or fullneOpen Document |